Latest filing published 18 Sept 2026 for Clene Inc., €1.2M. Read the official filing
Across 20 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Filings by David J. Matlin span 4 companies, the busiest being Clene Inc., TriSalus Life Sciences, Inc. and Lonestar Resources US Inc. The record holds 28 filings, for trades running from 24 May 2021 to 16 September 2026.
Purchases make up the whole of the open-market record (20 purchases, €8.2M). Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Other entries cover 4 share grants. Since January 2026: 1 purchase and no sales on the market.
Half of the purchases are above €146k and half below. 10 out of 20 purchases came within 30 days of a purchase by at least one other insider of the same company. Such overlaps are known as a cluster signal: distinct people reaching the same decision at about the same time.
The latest filing, published on 18 September 2026, reports a share grant of €1.2M in Clene Inc. The latest purchase dates back some time: it was published 278 days ago, on 13 January 2026. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. Section 16 rules allow two business days to file each Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 28 declarations